CEO LEADERSHIP SERIES

ASHTON TWEED'S CEO INTERVIEWS

November 9, 2018
Robert Bitterman

CEO Leadership Series: Robert Bitterman, President & CEO, Cutanea Life Sciences

PIVOTAL DECISION BRINGS NEW HORIZONS AND CHALLENGES After a long career in the pharmaceutical industry, Robert Bitterman decided to launch his own dermatology company, Cutanea Life […]
July 30, 2018
Bob Ward

CEO Leadership Series: Robert E. Ward, Chairman & CEO, Eloxx Pharmaceuticals

HOW TO TURN A COMPANY INTO A ‘TALENT MAGNET’ In the seven months since Robert E. Ward became Chairman and CEO at Eloxx Pharmaceuticals in Boston, […]
February 25, 2018
Patrick Treacy

CEO Leadership Series: Patrick J. Treacy, Co-Founder & CEO, Onkos Surgical

WHY FOCUS IS BOTH AN ASSET AND A CHALLENGE FOR THIS STARTUP Onkos Surgical, based in Parsippany, N.J., just hired its 34th employee, each one carefully […]
January 22, 2018
Ira Spector

CEO Leadership Series: Ira C. Spector, Ph.D., CEO, SFA Therapeutics

HOW NON-TRADITIONAL THINKING LED TO OPTIMIZED PROCESSES AND CAREER ADVANCEMENT Ira Spector has been CEO of SFA Therapeutics for six months, and the startup has hit […]
October 16, 2017
Geert Cauwenbergh

CEO Leadership Series: Geert Cauwenbergh, DR. MED. SC., President & CEO, RXi Pharmaceuticals Corp.

HOW TO CREATE SUCCESS AMID BIOTECH INDUSTRY’S UPS AND DOWNS When Dr. Geert Cauwenbergh became the President and CEO of RXi Pharmaceuticals Corp., he brought decades […]
August 21, 2017
Debbie Hart

CEO Leadership Series: Debbie Hart, President & CEO, BioNJ

SUPPORTING INNOVATION IN A RAPIDLY EVOLVING INDUSTRY In 1994, Debbie Hart became the founding president of BioNJ, a trade group that initially represented approximately 30 biotech […]
July 7, 2017
Jim Caruso

CEO Leadership Series: James Caruso, President & CEO, Cellectar Biosciences

HOW TO INFLUENCE A COMPANY’S CULTURE AND WHY IT MATTERS In his 27 years as a biotech and pharmaceutical professional, James Caruso has held key executive […]
May 19, 2017
Betsy Hanna

CEO Leadership Series: Elizabeth Hanna, President, Human Health, & Chief Operating Officer, Origin

WHY STRONG PLANNING AND EXECUTION SKILLS ARE VITAL TO EARLY-STAGE COMPANIES Elizabeth “Betsy” Hanna spent much of her career with large organizations – including pharma giants […]
April 7, 2017
Christopher Schaber

CEO Leadership Series: Christopher J. Schaber, PhD, President & CEO, Soligenix, Inc.

WALKING A TIGHTROPE BETWEEN DRUG DEVELOPMENT AND FUNDRAISING For Christopher J. Schaber, helming Soligenix Inc. involves walking a tightrope between developing a [...]
February 27, 2017
Cynthia Schwalm

CEO Leadership Series: Cynthia Schwalm, EVP, North America Commercial Operations, Ipsen

HOW TO MAKE TOUGH DECISIONS AND HELP OTHERS SUCCEED In the three years since Cynthia Schwalm joined Ipsen’s North America operations, she’s handled the enviable challenge […]
January 3, 2017
Elusys Logo

CEO Leadership Series: Elizabeth G. Posillico, PhD, President & CEO, Elusys Therapeutics, Inc.

HOW TO TRANSITION FROM AN R&D TO CLINICAL-STAGE CULTURE During the 11 years that Dr. Elizabeth G. “Tibby” Posillico has been President and CEO of Elusys Therapeutics, […]
November 17, 2016
Philip M. Sass

CEO Leadership Series: Philip M. Sass, Chairman, President & CEO, Liquid Biotech USA, Inc.

INVESTING IN THE FUTURE OF CANCER TREATMENT After co-founding and building Morphotek, Inc., a biotech company that specializes in developing biologics for the treatment of oncology, infectious […]
September 26, 2016

CEO Leadership Series: Scott Jackson, Former CEO, Celator Pharmaceuticals, Inc.

HOW WHEN PERSEVERANCE AND PASSION FINALLY PAY OFF When Scott Jackson became CEO of Celator Pharmaceuticals, Inc. more than eight years ago, a new treatment for […]
August 19, 2016
Gur Roshwalb, M.D.

CEO Leadership Series: Gur Roshwalb, MD, CEO, Akari Therapeutics Plc

HOW A MERGER JUMP-STARTED A PROMISING DRUG’S DEVELOPMENT Gur Roshwalb, M.D., isn’t afraid of a challenge. When Dr. Roshwalb, CEO of Akari Therapeutics Plc, saw a […]
July 11, 2016
Francois Nader, MD, MBA

CEO Leadership Series: Francois Nader, MD, Chairman, Acceleron Pharma Inc.

WHY CULTURE IS THE KEY TO A COMPANY’S SUCCESS Dr. Francois Nader knows something about the importance of embracing a culture, whether it’s on a personal […]
portrait of a businessman and a businesswoman leader

ARE YOU A CEO INTERESTED IN JOINING OUR LEADERSHIP SERIES?

CONTACT US TO DISCUSS AN INTERVIEW:

Jordan Warshafsky
Partner, Ashton Tweed Ltd.
Email: JWarshafsky@ashtontweed.com
Phone: 610.725.0290 x441

Ashton Tweed, Ltd.
565 E. Swedesford Rd.
Suite 214
Wayne, PA 19087